Regarding use of antihyperglycemic drugs, a recent review [32] concluded that using biguanides like metformin is associated with decreased total cancer risk, while sodium glucose cotransporter-2 inhibitors may increase bladder cancer risk [32]. This evidence concerns the gene SLC5A2 and urinary bladder cancer.